BIOVIE INC
For the period ended Jun 30, 2024. Filed Sep 30, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Sep 30, 2024
BIVI$1.30-2.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Changes in Stockholders’ Equity
For the Years Ended June 30, 2024 and 2023
| Accumulated | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Additional · Other · Total | ||||||||||
| Common Stock · Common Stock · Paid in · Treasury Stock · Treasury Stock · Comprehensive · Accumulated · Stockholders' | ||||||||||
| Shares · Amount · Capital · Shares · Amount · Income · Deficit · Equity | ||||||||||
| Balance, June 30, 2022 | 2,498,408 | $2,496 | $254,638,329 | - | $ | - | $ | - | $(250,969,890) | 3,670,935 |
| Stock option-based compensation | - | - | 4,222,845 | - | - | - | - | 4,222,845 | ||
| Stock-based compensation - restricted stock units | 21,518 | 21 | 1,780,028 | (2,288) | (2) | - | - | 1,780,047 | ||
| Stock-based compensation - issuance of common stock for services rendered | 5,000 | 5 | 372,495 | - | - | - | - | 372,500 | ||
| - | ||||||||||
| Cashless exercise of options | 2,256 | 3 | (3) | - | - | - | - | - | ||
| - | ||||||||||
| Cashless exercise of warrants | 359 | - | - | - | - | - | - | - | ||
| - | ||||||||||
| Proceeds from exercise of options | 80 | - | 2,240 | - | - | - | - | 2,240 | ||
| Proceeds from issuance of common stock, net costs of $2,008,898 | 753,925 | 754 | 49,464,349 | - | - | - | - | 49,465,103 | ||
| Proceeds from issuance of common stock, net of costs of $94,160 - Related Party | 363,636 | 364 | 5,905,476 | - | - | - | - | 5,905,840 | ||
| Unrealized gain on available-for-sale investments | - | - | - | - | - | 176,591 | - | 176,591 | ||
| Net loss | - | - | - | - | - | - | (50,255,815) | (50,255,815) | ||
| Balance, June 30, 2023 | 3,645,183 | 3,643 | 316,385,759 | (2,288) | (2) | 176,591 | (301,225,705) | 15,340,286 | ||
| Stock - based compensation - stock options | - | - | 2,823,764 | - | - | - | - | 2,823,764 | ||
| Stock-based compensation - restricted stock units | - | - | 1,763,450 | - | - | - | - | 1,763,450 | ||
| Proceeds from issuance of common stock, net of costs of $2,908,141 | 2,433,749 | 2,449 | 27,800,490 | - | - | - | - | 27,802,939 | ||
| Issuance of common stock from vesting of restricted stock units | 122,395 | 122 | (97) | (24,038) | (25) | - | - | - | ||
| Stock-based compensation - issuance of common stock for services rendered | 15,000 | 15 | 72,885 | - | - | - | - | 72,900 | ||
| Deemed dividend for ratchet adjustment to warrants | - | - | 886,423 | - | - | - | (886,423) | - | ||
| Relcassification of unrealized gains on available-for-sale investments upon settlement | - | - | - | - | - | (176,591) | - | (176,591) | ||
| Issuance of additional shares for fractional shares effected by the reverse split | 71 | - | - | - | - | - | - | - | ||
| Net Loss | - | - | - | - | - | - | (32,120,533) | (32,120,533) | ||
| Balance, June 30, 2024 | 6,216,398 | $6,229 | $349,732,674 | (26,326) | $(27) | $ | - | $(334,232,661) | $15,506,215 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.